Invention Grant
US08637567B2 Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid
有权
使用甘氨酰-L-2-甲基脯氨酰-L-谷氨酸的认知增强和认知疗法
- Patent Title: Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid
- Patent Title (中): 使用甘氨酰-L-2-甲基脯氨酰-L-谷氨酸的认知增强和认知疗法
-
Application No.: US12903844Application Date: 2010-10-13
-
Publication No.: US08637567B2Publication Date: 2014-01-28
- Inventor: Peter David Gluckman , Jian Guan , Mary-Anne Woodnorth , Margaret Anne Brimble
- Applicant: Peter David Gluckman , Jian Guan , Mary-Anne Woodnorth , Margaret Anne Brimble
- Applicant Address: NZ Auckland
- Assignee: Neuren Pharmaceuticals Ltd.
- Current Assignee: Neuren Pharmaceuticals Ltd.
- Current Assignee Address: NZ Auckland
- Agency: Borson Law Group, PC
- Agent D. Benjamin Borson
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/499
Abstract:
This invention provides compounds, compositions and methods for treating a cognitive disorder or memory disorder in animals that result from aging or other neurodegenerative condition. In particular, compounds of this invention can stimulate neural cell growth, increased amounts of cells containing a key enzyme needed for production of the cholinergic neurotransmitter, and can improve memory and cognitive function in animals who have experienced a loss of memory or cognitive function.
Public/Granted literature
- US20110112033A1 COGNITIVE ENHANCEMENT AND COGNITIVE THERAPY USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID Public/Granted day:2011-05-12
Information query
